Newsletter | May 15, 2024

05.15.24 -- "Holy T7 Polymerase, Batman!" Next-Gen IVT Considerations


Clinical Research As A Delicate Ecosystem

Making the right outsourcing decision can significantly contribute to the success and growth of your program, providing essential support and resources that empower it to thrive in its objectives and endeavors. Entrust that your program is in hands you can rely on, where integrity is paramount, and excellence is the standard.


A Promising Approach For An Inhalable, Temperature-Stable COVID Vaccine

There are limitations to the currently available COVID-19 vaccines. An inhalable dry powder approach offers promising benefits, such as eliminating cold chain requirements, for more widespread immunity.

“Holy T7 Polymerase, Batman!” R&D Considerations For Awe-Inspiring xRNA

It goes without saying we have some ambitious therapeutic goals for linear mRNA and next-gen saRNA and circRNA. However, as my conversation with Koeris explored, we still have a lot of scientific and technical work/innovation ahead of us to make our RNA products “stronger” (in more ways than one).

AI & Pharmaceutical Development: WHO Calls For Ethical Framework

The World Health Organization (WHO) recently released a document titled Benefits and risks of using artificial intelligence for pharmaceutical development and delivery describing the ethical issues and governance considerations for using AI in drug discovery, preclinical development, and clinical trials.


Staying On Top Of Changing FDA Regulations To Avoid Clinical Holds

As the biotech industry has grown exponentially, so has the number of FDA clinical holds. Biotech companies need strategic planning to avoid or quickly resolve costly clinical holds.

Demand More From Your Oligo Synthesizer

The market for oligonucleotide therapeutics is expanding, and the pipeline is diverse. Gain insight into how you can fast-track your molecule's development.

Keys To Successful mRNA Manufacturing

How can PCR-based technology accelerate mRNA development and manufacturing and design principles/critical parameters to enable the rapid development of lipids for RNA formulation?

Can mRNA Disrupt The Biopharma Industry?

mRNA has the potential to revolutionize the field of vaccine development. However, it is critical we understand any factors that could impact its successful entry into today’s market.